Prognostic significance of lymphovascular invasion in radical cystectomy on patients with bladder cancer: A systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Kim, Hwanik ^a   Kim, Myong ^a   Kwak, Cheol ^a   Kim, Hyeon Hoe ^a   Ku, Ja Hyeon ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; CANCER GRADING; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CYSTECTOMY; DIAGNOSTIC VALUE; HUMAN; LYMPH VESSEL METASTASIS; META ANALYSIS; OVERALL SURVIVAL; RECURRENCE FREE SURVIVAL; REVIEW; SYSTEMATIC REVIEW; LYMPH NODE METASTASIS; PATHOLOGY; PROCEDURES; PROGNOSIS; TUMOR INVASION; URINARY BLADDER NEOPLASMS;

CYSTECTOMY; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 84896774931     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089259     Document Type: Review

References (48)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer 62: 10-29.
2. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, et al. (1994) Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466. (Pubitemid 24079885)
3. Herman CM, Wilcox GE, Kattan MW, Scardino PT, Wheeler TM (2000) Lymphovascular invasion as a predictor of disease progression in prostate cancer. Am J Surg Pathol 24: 859-863. (Pubitemid 30366274)
4. Ku JH, Byun SS, Jeong H, Kwak C, Kim HH, et al. (2013) Lymphovascular invasion as a prognostic factor in the upper urinary tract urothelial carcinoma: A systematic review and meta-analysis. Eur J Cancer49: 2665-2680.
5. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
6. de Graeff P, Crijns AP, de Jong S, Boezen M, Post WJ, et al. (2009) Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis. Br J Cancer 101: 149-159.
7. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, et al. (2005) Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93: 387-391.
8. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17: 2815-2834. (Pubitemid 28562978)
9. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
10. Türkölmez K, Tokgöz H, Reşorlu B, Köse K, Bedük Y (2007) Muscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors. Urology 70: 477-81.
11. Canter D, Guzzo T, Resnick M, Magerfleisch L, Sonnad S, et al. (2008) The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis. BJU Int 102: 952-957.
12. Matsumoto K, Satoh T, Irie A, Ishii J, Kuwao S, et al. (2008) Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer. Urology 72: 444-9.
13. Fairey AS, Jacobsen NE, Chetner MP, Mador DR, Metcalfe JB, et al. (2009) Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database. J Urol 182: 85-92.
14. Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, et al. (2009) The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. BJU Int 103: 475-479.
15. Hugen CM, Polcari AJ, Fitzgerald MP, Dauw C, Flanigan RC, et al. (2010) Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer. J Surg Oncol 102: 334-337.
16. Kim DS, Cho KS, Lee YH, Cho NH, Oh YT, et al. (2010) High-grade hydronephrosis predicts poor outcomes after radical cystectomy in patients with bladder cancer. J Korean Med Sci 25: 369-73.
17. Ku JH, Moon KC, Kwak C, Kim HH (2010) Influence of stage discrepancy on outcome in patients treated with radical cystectomy. Tumori 96: 699-703.
18. Manoharan M, Katkoori D, Kishore TA, Jorda M, Luongo T, et al. (2010) Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases? World J Urol 28: 233-237.
19. Palmieri F, Brunocilla E, Bertaccini A, Guidi M, Pernetti R, et al. (2010) Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy. Anticancer Res 30: 2973-2976.
20. Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, et al. (2010) International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 105: 1402-1412.
21. Stephenson AJ, Gong MC, Campbell SC, Fergany AF, Hansel DE (2010) Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer. Urology 75: 382-386.
22. Font A, Taron M, Gago JL, Costa C, Sánchez JJ, et al. (2011) BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer. Ann Oncol 22: 139-144.
23. Kauffman EC, Ng CK, Lee MM, Otto BJ, Wang GJ, et al. (2011) Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy. BJU Int 107: 628-635.
24. Park E, Ha HK, Chung MK (2011) Prediction of prognosis after radical cystectomy for pathologic node-negative bladder cancer. Int Urol Nephrol 43: 1059-1065.
25. Park J, Kim S, Jeong IG, Song C, Hong JH, et al. (2011) Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy? World J Urol 29: 443-449.
26. Gondo T, Nakashima J, Ozu C, Ohno Y, Horiguchi Y, et al. (2012) Risk stratification of survival by lymphovascular invasion, pathological stage, and surgical margin in patients with bladder cancer treated with radical cystectomy. Int J Clin Oncol 17: 456-461.
27. Otto W, May M, Fritsche HM, Dragun D, Aziz A, et al. (2012) Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gend Med 9: 481-489.
28. Afonso J, Longatto-Filho A, Martinho O, Lobo F, Amaro T, et al. (2013) Low RKIP expression associates with poor prognosis in bladder cancer patients. Virchows Arch 462: 445-453.
29. Eisenberg MS, Boorjian SA, Cheville JC, Thompson RH, Thapa P, et al. (2013) The SPARC (Survival Prediction After Radical Cystectomy) Score: A Multifactorial Outcome Prediction Model for Patients Undergoing Radical Cystectomy for Bladder Cancer. J Urol 190(6): 2005-10. doi: 10.1016/j.juro.2013. 06.022.
30. Lotan Y, Bagrodia A, Passoni N, Rachakonda V, Kapur P, et al. (2013) Prospective Evaluation of a Molecular Marker Panel for Prediction of Recurrence and Cancer-specific Survival After Radical Cystectomy. Eur Urol 64(3): 465-71. doi:10.1016/j.eururo.2013.03.043.
31. Dicken BJ, Saunders LD, Jhangri GS, de Gara C, Cass C, et al. (2004) Gastric cancer: establishing predictors of biologic behavior with use of population-based data. Ann Surg Oncol 11: 629-635. (Pubitemid 40486721)
32. Woo CS, Silberman H, Nakamura SK, Ye W, Sposto R, et al. (2002) Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer. Am J Surg 184: 337-340. (Pubitemid 35287354)
33. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, et al. (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296: 1883-1886. (Pubitemid 34596277)
34. Alitalo K, Mohla S, Ruoslahti E (2004) Lymphangiogenesis and cancer: meeting report. Cancer Res 64: 9225-9229. (Pubitemid 39665539)
35. Kikuchi E, Margulis V, Karakiewicz PI, Roscigno M, Mikami S, et al. (2009) Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 27: 612-618.
36. Kikuchi E, Horiguchi Y, Nakashima J, Hatakeyama N, Matsumoto M, et al. (2005) Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol 174: 2120-2123. (Pubitemid 41611749)
37. Akao J, Matsuyama H, Yamamoto Y, Hara T, Kawai Y, et al. (2008) Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer. BJU Int 102: 572-575.
38. Alexander-Sefre F, Singh N, Ayhan A, Salveson HB, Wilbanks G, et al. (2003) Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry. J Clin Pathol 56: 786-788. (Pubitemid 37243943)
39. Capdet J, Martel P, Charitansky H, Lim YK, Ferron G, et al. (2009) Factors predicting the sentinel node metastases in T1 breast cancer tumor: an analysis of 1416 cases. Eur J Surg Oncol 35: 1245-1249.
40. Lee KB, Ki KD, Lee JM, Lee JK, Kim JW, et al. (2009) The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study. Ann Surg Oncol 16: 2882-2887.
41. Meier I, Merkel S, Papadopoulos T, Sauer R, Hohenberger W, et al. (2008) Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition. Int J Radiat Oncol Biol Phys 70: 1408-1417. (Pubitemid 351417761)
42. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, et al. (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20: 1527-1536. (Pubitemid 34260532)
43. Albers P, Siener R, Kliesch S, Weissbach L, Krege S, et al. (2003) German Testicular Cancer Study Group. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol 21: 1505-1512. (Pubitemid 46594103)
44. Egger M, Zellweger-Zähner T, Schneider M, Junker C, Lengeler C, et al. (1997) Language bias in randomised controlled trials published in English and German. Lancet 350: 326-9. (Pubitemid 27351115)
45. Margulis V, Lotan Y, Montorsi F, Shariat SF (2008) Predicting survival after radical cystectomy for bladder cancer. BJU Int 102: 15-22. (Pubitemid 351799452)
46. Chromecki TF, Bensalah K, Remzi M, Verhoest G, Cha EK, et al. (2011) Prognostic factors for upper urinary tract urothelial carcinoma. Nat Rev Urol 8: 440-447.
47. Miyata Y, Kanda S, Ohba K, Nomata K, Eguchi J, et al. (2006) Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis. J Urol 176: 348-353. (Pubitemid 43815391)
48. Straume O, Jackson DG, Akslen LA (2003) Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 9: 250-256. (Pubitemid 36109741)